TCR2 Therapeutics | 4:持股变动声明-股东 TANG KEVIN C
02/15 06:29
TCR2 Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-TANG CAPITAL PARTNERS, LP(0%),TANG CAPITAL MANAGEMENT, LLC(0%)等
02/15 05:03
TCR2 Therapeutics | 15-12G:终止注册
2023/06/12 19:00
TCR2 Therapeutics | EFFECT:其他
2023/06/06 12:15
TCR2 Therapeutics | EFFECT:其他
2023/06/06 12:15
TCR2 Therapeutics | EFFECT:其他
2023/06/06 12:15
TCR2 Therapeutics | 4:持股变动声明-股东 UBS Oncology Impact Fund L.P.
2023/06/06 04:37
TCR2 Therapeutics | 4:持股变动声明-股东 MPM SunStates Fund, L.P.
2023/06/06 04:36
TCR2 Therapeutics | 4:持股变动声明-股东 MPM BioVentures 2014, L.P.
2023/06/06 04:36
TCR2 Therapeutics | 4:持股变动声明-董事 GADICKE ANSBERT
2023/06/06 04:35
TCR2 Therapeutics | POS AM:修改注册声明表
2023/06/02 04:45
TCR2 Therapeutics | POS AM:修改注册声明表
2023/06/02 04:44
TCR2 Therapeutics | POS AM:修改注册声明表
2023/06/02 04:43
TCR2 Therapeutics | S-8 POS:员工福利计划证券登记(修正)
2023/06/02 04:41
TCR2 Therapeutics | S-8 POS:员工福利计划证券登记(修正)
2023/06/02 04:41
TCR2 Therapeutics | S-8 POS:员工福利计划证券登记(修正)
2023/06/02 04:40
TCR2 Therapeutics | S-8 POS:员工福利计划证券登记(修正)
2023/06/02 04:39
TCR2 Therapeutics | S-8 POS:员工福利计划证券登记(修正)
2023/06/02 04:38
TCR2 Therapeutics | 4:持股变动声明-董事 Allen Andrew R
2023/06/02 04:33
TCR2 Therapeutics | 4:持股变动声明-董事 Tomasello Shawn
2023/06/02 04:32
暂无数据
暂无数据